(SURG) Surgepays - Ratings and Ratios

SurgePays, Inc. operates as a financial technology and telecommunications company, focusing on delivering connectivity and payment solutions across multiple industries. The company is structured into three core business segments: Mobile Virtual Network Operators (MVNOs), Comprehensive Platform Services, and Lead Generation. Through its MVNO segment, SurgePays provides both subsidized and non-subsidized mobile broadband services, enabling internet access for consumers. The Comprehensive Platform Services division offers ACH banking solutions, fintech transaction platforms, and wireless product aggregation, primarily targeting convenience stores. Additionally, the Lead Generation segment specializes in case management and lead acquisition services for law firms in the mass tort industry, supported by call center operations.

SurgePays, Inc. is headquartered in Bartlett, Tennessee, and trades on the NASDAQ under the ticker symbol SURG. The company is classified under the Wireless Telecommunication Services industry within the GICS framework. Its current market capitalization stands at approximately $25.81 million, with a forward P/E ratio of 8.00, reflecting expectations for future earnings growth. The stock has a price-to-book ratio of 0.78 and a price-to-sales ratio of 0.31, indicating a valuation that may align with its growth potential. However, the companys return on equity (RoE) is currently negative at -69.05%, signaling ongoing profitability challenges.

From a technical standpoint, SURG has shown a 20-day average volume of 102,239 shares, with a last price of $1.37. The stocks short-term moving averages (SMA 20: 1.34, SMA 50: 1.52) suggest recent price weakness, while the SMA 200 (2.13) indicates a broader downtrend. The average true range (ATR) of 0.09 reflects relatively low volatility in recent trading activity.

3-Month Forecast: Month 1: - Technical Outlook: The stock is likely to face resistance at the SMA 50 level (1.52) and may experience selling pressure as it approaches this threshold. Support is expected to hold around the SMA 20 (1.34), but a break below this level could signal further downside. - Target Price Range: $1.25 - $1.45 Month 2: - Technical Outlook: If the stock fails to breach the SMA 50, it may enter a consolidation phase, with price action confined between $1.15 and $1.35. The ATR of 0.09 suggests minimal volatility, but the broader downtrend (SMA 200: 2.13) could weigh on sentiment. - Target Price Range: $1.15 - $1.35 Month 3: - Fundamental Outlook: The companys low P/S ratio (0.31) and P/B ratio (0.78) may attract value investors, but the negative RoE (-69.05%) remains a concern. If operational improvements are announced, the stock could see a rebound toward the SMA 50 level. - Target Price Range: $1.15 - $1.35 Overall Technical and Fundamental Outlook: The stock is expected to remain range-bound over the next three months, with potential for modest upside if the company demonstrates progress in addressing its profitability challenges. However, the broader technical downtrend and negative RoE suggest caution for investors.